Sepracor's "Product And Use" Lunesta Ad To Be "Very Visible," Company Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Sepracor's Lunesta (eszopiclone) "product and use" ad campaign will "be very visible going forward," the company said during its April 25 earnings call